We came across a bullish thesis on Ultragenyx Pharmaceutical Inc. on HalfBakedInnovations’s Substack by Biotech Distilled. In ...
AbbVie expects these two drugs to generate more than $31 billion in sales in 2026 — about $0.5 billion above its long-term ...
We are thrilled to welcome Elaine to Artiva’s board at such an important time for the company,” said Fred Aslan, M.D., president and chief executive officer of Artiva Biotherapeutics. “Elaine brings ...
AbbVie recently reported record 2025 results and outlined a stronger 2026 outlook, while advancing key immunology assets and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results